*InvestingPro Notes +Management has been aggressively buying back shares -Analysts anticipate sales decline in the current year +Prominent player in the Insurance industry /Short term obligations exceed liquid assets
Metric Name Value Market Cap (Adjusted) 45.435 B Price / Book 1.0x Avg Price / Book (10y) 0.8x Predicted Price / Book 1.0x P/E Ratio 11.9x Avg P/E Ratio (10y) 0.2x EV / EBITA 11.8x Avg EV / EBITDA (10y) 9.7x Market Cap / LTM Revenue 1.0x Revenue Growth 38.8% Revenue Growth Forecast -42.3% Revenue 45.299 B Net Income to Company -2.3 B EBITDA 8.501 B EBITDA Growth 8.5% EBITDA CAGR (5y) 3.6% EBITDA Growth Forecast 13.0% Common Equity 45.039 B Total Debt / Total Capital 18.1% Current Ratio 0.6x Dividend Yield 2.2% Operating Income Trend Score 25.0%
🎁Great Opportunity! Be one step ahead in the world of investment with Investing Pro+! Now with a channel-specific +15% discount and a total of 70%, don't miss this opportunity! 📈 CODE: sepethissepro
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.